When I first read the news, the headline felt like a eulogy: a 49-year-old mattress retailer, a fixture of Upstate New York, was turning off the lights for good. Metro Mattress, a...
The Akero Therapeutics Buyout: A Tale Told by Insider Selling ============================================================ The news cycle loves a big number. And the news that Aker...
So United Airlines just dropped its Summer 2026 schedule, and the PR machine is working overtime to convince us they’ve reinvented international travel. The press release is a mast...
So, Novo Nordisk just dropped $5.2 billion on a company called Akero Therapeutics. The stock market cheered (prompting headlines like Why Akero Therapeutics Stock Trounced the Mark...
So, let me get this straight. The Department of Education is blasting out emails with the subject line, "You're eligible to have your student loan(s) discharged." Two million peopl...
For decades, we’ve been told the same story about American cities like Erie, Pennsylvania. It’s a narrative of decline, of shuttered factories and a generation of talent leaving fo...
I’ve spent my career watching technologies emerge, and every so often, you witness a moment that feels different. It’s not just an upgrade or an iteration; it’s a fundamental shift...
Gold's Record High Isn't About Money—It's a Barometer for Our Global Fever When gold smashed through the $4,000 barrier last week, the financial world treated it like a sports scor...
Tilray's 25% Surge: A Closer Look at the Numbers Behind the Noise The ticker tape doesn’t have emotions. It just prints numbers. On Thursday morning, the numbers for Tilray Brands...
The Two Faces of Jamie Dimon: Dissecting the CEO's Contradictory Market Signals There are two Jamie Dimons operating in the market right now. The first is the one who appeared in B...